Ceres Nanosciences, Inc.
Ceres Nanosciences, Inc. is a privately held company based in Northern Virginia, specializing in the development and commercialization of Nanotrap® hydrogel particle technology. Their mission is to deliver innovative products powered by Nanotrap Technology to address life science needs and provide better patient outcomes. Ceres' products enable the capture, concentration, and preservation of low-abundance analytes from diverse biological and environmental samples, supporting applications in diagnostics, research, and public health surveillance. The company is ISO 9001:2015 certified and collaborates with leading research institutions, public health agencies, and industry partners to advance global health security and biosecurity. Ceres has established a national network of Wastewater-based Epidemiology Centers of Excellence and has received significant funding from the NIH RADx initiative and other organizations to expand its impact in underserved communities. Their technology is widely adopted for wastewater-based epidemiology, proteomics, and nucleic acid analysis, with a strong focus on supporting public health monitoring, early detection of infectious diseases, and environmental bio-surveillance.
Industries
Nr. of Employees
small (1-50)
Ceres Nanosciences, Inc.
Patents
Method for harvesting nanoparticles and sequestering biomarkers
2016-07-05 • US-9383299-B2
View DetailsMethod for harvesting nanoparticles and sequestering biomarkers
2013-02-26 • US-8382987-B2
View Details
Method for harvesting nanoparticles and sequestering biomarkers
2016-07-05 • US-9383299-B2
View DetailsMethod for harvesting nanoparticles and sequestering biomarkers
2013-02-26 • US-8382987-B2
View DetailsProducts
Magnetically functionalized hydrogel particles for microbial concentration
Magnetic hydrogel particle formulations designed to capture and concentrate viruses, bacteria, and other microbes from clinical and environmental samples for downstream nucleic acid analysis.
Particle formulations for extracellular vesicle capture
Particle formulations for direct capture and concentration of extracellular vesicles from dilute biological samples to enable downstream EV-RNA and protein analyses.
cfDNA enrichment kit using hydrogel particle capture
A kit-based workflow that uses hydrogel particles for size-selective and affinity capture to enrich and purify cell-free DNA from plasma while reducing high-molecular-weight genomic DNA contamination; available for manual and semi-automated processing across typical plasma volumes.
Affinity-based protein/peptide enrichment kits for proteomics
Kits containing multiple particle chemistries to enrich low-molecular-weight and low-abundance proteins and peptides from biofluids prior to digestion and mass spectrometry to increase proteome depth and reproducibility.
Particle handling buffers and enhancement reagents
Buffer and reagent products designed to improve particle handling (reduce tube adhesion), dilute viscous samples, homogenize solids, and enhance microbial binding in wastewater samples to improve downstream nucleic acid recovery.
Magnetically functionalized hydrogel particles for microbial concentration
Magnetic hydrogel particle formulations designed to capture and concentrate viruses, bacteria, and other microbes from clinical and environmental samples for downstream nucleic acid analysis.
Particle formulations for extracellular vesicle capture
Particle formulations for direct capture and concentration of extracellular vesicles from dilute biological samples to enable downstream EV-RNA and protein analyses.
cfDNA enrichment kit using hydrogel particle capture
A kit-based workflow that uses hydrogel particles for size-selective and affinity capture to enrich and purify cell-free DNA from plasma while reducing high-molecular-weight genomic DNA contamination; available for manual and semi-automated processing across typical plasma volumes.
Affinity-based protein/peptide enrichment kits for proteomics
Kits containing multiple particle chemistries to enrich low-molecular-weight and low-abundance proteins and peptides from biofluids prior to digestion and mass spectrometry to increase proteome depth and reproducibility.
Particle handling buffers and enhancement reagents
Buffer and reagent products designed to improve particle handling (reduce tube adhesion), dilute viscous samples, homogenize solids, and enhance microbial binding in wastewater samples to improve downstream nucleic acid recovery.
Expertise Areas
- Sample preparation and low-abundance analyte concentration
- Wastewater-based epidemiology and environmental surveillance network deployment
- Liquid biopsy cfDNA enrichment and pre-analytical workflows
- Extracellular vesicle isolation for RNA and protein analysis
Key Technologies
- Hydrogel affinity particles for analyte capture
- Magnetic particle separation and recovery
- Automated magnetic-bead and liquid-handling integration
- Digital PCR genotyping workflows
Key People
News & Updates
Received Gates Foundation funding to support deployment of wastewater biosecurity products to global health testing sites in Africa and India.
Received funding to launch a new global product for biosecurity and disease surveillance.
Launched new Nanotrap® Extracellular Vesicle Particles for improved isolation from complex samples.
Awarded $8.2 million from the NIH RADx Initiative to support the development and implementation of wastewater-based surveillance systems for COVID-19, with an emphasis on underserved and vulnerable populations.
Completed a new 12,000-square-foot Advanced Particle Manufacturing Plant to expand Nanotrap® Particle manufacturing capacity for COVID-19 testing and future needs.
Assesses genome coverage across wastewater samples and demonstrates a scalable, high-throughput solution for near real-time influenza surveillance.
Received Gates Foundation funding to support deployment of wastewater biosecurity products to global health testing sites in Africa and India.
Received funding to launch a new global product for biosecurity and disease surveillance.
Launched new Nanotrap® Extracellular Vesicle Particles for improved isolation from complex samples.
Awarded $8.2 million from the NIH RADx Initiative to support the development and implementation of wastewater-based surveillance systems for COVID-19, with an emphasis on underserved and vulnerable populations.
Completed a new 12,000-square-foot Advanced Particle Manufacturing Plant to expand Nanotrap® Particle manufacturing capacity for COVID-19 testing and future needs.
Assesses genome coverage across wastewater samples and demonstrates a scalable, high-throughput solution for near real-time influenza surveillance.